Liver-specific microRNA-122
暂无分享,去创建一个
[1] Chris Sander,et al. Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.
[2] W. Filipowicz,et al. Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.
[3] K. Ghoshal,et al. Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas , 2006, Journal of cellular biochemistry.
[4] V. Ambros,et al. An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.
[5] S. Thorgeirsson,et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.
[6] Catherine L Jopling,et al. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. , 2008, Cell host & microbe.
[7] C. Croce,et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. , 2009, Cancer research.
[8] P. Sarnow,et al. Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex , 2011, Proceedings of the National Academy of Sciences.
[9] W. Filipowicz,et al. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy , 2009, Nature Medicine.
[10] K. Norman,et al. Modulation of Hepatitis C Virus RNA Abundance and the Isoprenoid Biosynthesis Pathway by MicroRNA miR-122 Involves Distinct Mechanisms , 2009, Journal of Virology.
[11] Charles M. Rice,et al. Unravelling hepatitis C virus replication from genome to function , 2005, Nature.
[12] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[13] T. Katoh,et al. Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. , 2009, Genes & development.
[14] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[15] Y. Hayashizaki,et al. A comprehensive survey of 3' animal miRNA modification events and a possible role for 3' adenylation in modulating miRNA targeting effectiveness. , 2010, Genome research.
[16] T. Tuschl,et al. Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.
[17] T. Tuschl,et al. Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.
[18] A. Silahtaroglu,et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver , 2007, Nucleic acids research.
[19] L. Lim,et al. An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.
[20] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[21] Mark Graham,et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. , 2006, Cell metabolism.
[22] S. Lemon,et al. miR-122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes. , 2010, Antiviral research.
[23] Ashley P E Roberts,et al. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components , 2011, Nucleic acids research.
[24] V. Kim,et al. Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.
[25] W. Filipowicz,et al. Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.
[26] Hsien-Da Huang,et al. MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma , 2009, Hepatology.
[27] K. Ghoshal,et al. MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib* , 2009, The Journal of Biological Chemistry.
[28] S. Zeuzem,et al. 58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION , 2012 .
[29] Charles E. Vejnar,et al. Integration of microRNA miR-122 in hepatic circadian gene expression. , 2009, Genes & development.
[30] A. D’Ambrogio,et al. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation , 2011, Nature.
[31] A. Bradley,et al. Identification of mammalian microRNA host genes and transcription units. , 2004, Genome research.
[32] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[33] Anton J. Enright,et al. Genomic analysis of human microRNA transcripts , 2007, Proceedings of the National Academy of Sciences.
[34] S. Lemon,et al. Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122 , 2010, Journal of Virology.
[35] C. Richardson,et al. Human Ago2 Is Required for Efficient MicroRNA 122 Regulation of Hepatitis C Virus RNA Accumulation and Translation , 2010, Journal of Virology.
[36] F. Chisari. Unscrambling hepatitis C virus–host interactions , 2005, Nature.
[37] C. Sander,et al. miR-122, a Mammalian Liver-Specific microRNA, is Processed from hcr mRNA and MayDownregulate the High Affinity Cationic Amino Acid Transporter CAT-1 , 2004, RNA biology.
[38] De-Pei Liu,et al. Positive regulation of hepatic miR-122 expression by HNF4α. , 2011, Journal of hepatology.
[39] Ana Kozomara,et al. miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..
[40] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[41] Michael Niepmann,et al. microRNA-122 stimulates translation of hepatitis C virus RNA , 2008, The EMBO journal.
[42] H. Horvitz,et al. MicroRNA Expression in Zebrafish Embryonic Development , 2005, Science.
[43] V. Beneš,et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. , 2011, The Journal of clinical investigation.